XBI
State Street SPDR S&P Biotech ETF
Price Chart
Latest Quote
$153.57
+3.10 (+2.06%)
Current Price
| Previous Close | $150.47 |
| Open | $150.35 |
| Day High | $154.12 |
| Day Low | $149.37 |
| Volume | 4,668,043 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.35% |
| Net Assets | $10.36B |
| Expense Ratio | 0.35% |
| Category | Health |
| Fund Family | State Street Investment Management |
| Net Asset Value | $150.54 |
| Premium/Discount | 2.01% |
| Quarterly Dividend Yield | 0.35% |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $151.26 |
| SMA50 | $157.01 |
| SMA200 | $141.08 |
| RSI | 54.50 |
| ATR | 4.3507 |
| Rel Volume | 0.49 |
Performance History
| Week | +0.24% |
| Month | -1.92% |
| Quarter | +3.85% |
| 6 Months | +17.23% |
| YTD | +26.53% |
| Year | +42.33% |
| 3 Years | +130.99% |
| 5 Years | +24.99% |
| 10 Years | +172.64% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $153.57 | 4,668,043 |
| 2026-10-26 | $150.47 | 4,820,200 |
| 2026-10-23 | $149.54 | 6,608,000 |
| 2026-10-22 | $151.64 | 11,602,900 |
| 2026-10-21 | $152.78 | 8,293,800 |
| 2026-10-20 | $153.24 | 12,362,800 |
| 2026-10-19 | $147.86 | 8,386,200 |
| 2026-10-16 | $144.32 | 11,754,100 |
| 2026-10-15 | $149.78 | 11,509,600 |
| 2026-10-14 | $146.77 | 10,379,500 |
| 2026-10-13 | $146.80 | 9,753,100 |
| 2026-10-12 | $151.40 | 6,044,900 |
| 2026-10-09 | $153.77 | 12,133,600 |
| 2026-10-08 | $149.29 | 12,923,400 |
| 2026-10-07 | $150.23 | 9,535,900 |
| 2026-10-06 | $150.90 | 17,220,200 |
| 2026-10-05 | $156.19 | 6,989,500 |
| 2026-10-02 | $154.43 | 8,747,700 |
| 2026-10-01 | $154.51 | 11,568,400 |
| 2026-09-30 | $157.68 | 6,867,500 |
| 2026-09-29 | $156.81 | 8,389,800 |
| 2026-09-28 | $156.61 | 7,140,200 |
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
đ° Latest News
No news articles available at the moment. Check back later for updates on XBI.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.